Clinical Cancer Research Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, X. W.
Right arrow Articles by Zhang, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, X. W.
Right arrow Articles by Zhang, M.
Clinical Cancer Research Vol. 12, 2849-2855, May 1, 2006
© 2006 American Association for Cancer Research


Cancer Therapy: Preclinical

Antisense Oligonucleotide Inhibition of Tumor Necrosis Factor Receptor 1 Protects the Liver from Radiation-Induced Apoptosis

Xiao W. Huang1, Jiong Yang2, Aleksandar F. Dragovic2, Hong Zhang3, Theodore S. Lawrence2 and Ming Zhang2

Authors' Affiliations: 1 Liver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, China; 2 Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan; and 3 Isis Pharmaceuticals, Carlsbad, California

Requests for reprints: Ming Zhang, Department of Radiation Oncology, University of Michigan, 1331 East Ann Street, Room 3111, Ann Arbor, MI 48109-0582. Phone: 734-763-7286; Fax: 734-763-1581; E-mail: mingz{at}med.umich.edu.

Purpose: Liver damage by radiation limits its efficacy in cancer treatment. As radiation can generate apoptotic signals, we wished to examine the potential to protect the liver by inhibiting apoptosis through two key mediators, FAS and tumor necrosis factor receptor 1 (TNFR1).

Experimental Design: Radiation-induced liver damage was assessed by serum aspartate aminotransferase and alanine aminotransferase, hepatocyte micronucleus formation, and apoptosis assays (terminal nucleotidyl transferase–mediated nick end labeling and caspase-3 cleavage) in mice. Protection was evaluated by pretreating mice with antisense oligonucleotides (ASO) for FAS or TNFR1 prior to radiation. TNF-{alpha} production in liver and in Kupffer cells were determined by ELISA.

Results: Radiation increased liver FAS and TNFR1 transcription in a dose- and time-dependent manner (maximized at 25 Gy and 8 hours postirradiation). Pretreatment with ASOs for FAS and TNFR1 resulted in the inhibition of liver FAS and TNFR1 by 78% and 59%, respectively. Inductions of serum aspartate aminotransferase and alanine aminotransferase were observed at 2 hours after radiation and could be reduced by pretreating mice with ASO for TNFR1 but not FAS or control oligonucleotide. Radiation-induced liver apoptosis (terminal nucleotidyl transferase–mediated nick end labeling staining and caspase-3 activation on Western blot) and hepatocyte micronucleus formation were reduced by pretreatment with ASO for TNFR1. In addition, radiation stimulated TNF-{alpha} production both in irradiated liver and in cultured Kupffer cells by >50% and 100%, respectively.

Conclusion: This study suggests that ionizing radiation activates apoptotic signaling through TNFR1 in the liver, and thus provides a rationale for anti-TNFR1 apoptotic treatment to prevent radiation-induced liver injury.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. Zhang, J. Qian, X. Xing, F.-M. Kong, L. Zhao, M. Chen, and T. S. Lawrence
Inhibition of the Tumor Necrosis Factor-{alpha} Pathway Is Radioprotective for the Lung
Clin. Cancer Res., March 15, 2008; 14(6): 1868 - 1876.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.